Europe GMP Testing Service Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Service Type (Product Validation Testing, Bioanalytical Services, Packaging & Shelf Life Testing, and Other Services Type) and End User (Pharmaceutical and Bio

Europe GMP Testing Service Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Service Type (Product Validation Testing, Bioanalytical Services, Packaging & Shelf Life Testing, and Other Services Type) and End User (Pharmaceutical and Biopharmaceutical Companies, and Medical Device Companies)

The Europe GMP testing service market is expected to grow from US$ 616.77 million in 2022 to US$ 897.22 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028.

Expansions Concerning GMP Testing Services Boost Europe GMP Testing Service Market Growth

Many life sciences companies are new to the concept of adopting robotics and cognitive automation (R&CA). The USFDA Regulation 21 requirements have led to uncertainties about R&CA, and their potential impact on human safety has decelerated the progress of the GMP testing industry. Despite the lag in technology adoption, the use of automation is gradually becoming commonplace across pharmaceutical, medical device, and biotechnology companies, especially in various stages of clinical trials and regulatory compliance. Industry 4.0—enabling connectivity, advanced analytics, robotics, and automation—can revolutionize every aspect of pharmaceutical manufacturing in the next 5–10 years. The initial use cases of Industry 4.0 in pharmaceutical manufacturing have been demonstrated to deliver a 30–40% surge in productivity in mature and efficient lab environments; further improvements could lead to more than 50% reductions in the overall quality-control costs. Digitization and automation ensure better quality and compliance by reducing manual errors and variability, simultaneously enabling the faster and more effective addressal of problems. Robotic process automation and cognitive automation, and validation are likely to contribute to the following processes, as a part of GMPs:

Streamlining the tedious product labeling process, supporting advancements in pharmacovigilance by providing tools and ability to process product quality and distribution data Maintaining official records required by predicate rules that are subject to inspection under FDA requirements, such as study protocols for new drug applications Enhancing the effectiveness of training and learning management systems (LMS) by automating training assignments, identifying gaps, and facilitating communications with respective personnel Identifying high-risk abnormalities in images, such as radiology reports, through large-scale interpretation and processing of the data of clinical trials.

Europe GMP Testing Service Market Overview

The Europe GMP testing service market is subsegmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Rest of Europe consists of countries such as Poland, Austria, Switzerland, Sweden, Norway, Ireland, Denmark, Belgium, and the Netherlands. Europe holds a significant share of the global GMP testing services market and is estimated to record a notable CAGR during the forecast period. The market growth in the region is attributed to the proliferation of the pharmaceuticals, biopharmaceuticals, biotechnology, and medical device industries; product innovations by the market players; and the rising prevalence of chronic diseases.

Europe GMP testing service Market Revenue and Forecast to 2028 (US$ Million)

Europe GMP testing service Market Segmentation

The Europe GMP testing service market is segmented on the basis of service type, end user, and country. Based on service type, the Europe GMP testing service market is segmented into product validation testing, bioanalytical services, packaging & shelf-life testing, and other services type. The product validation testing segment held the largest market share in 2022.

Based on end user, the Europe GMP testing service market is bifurcated into pharmaceutical and biopharmaceutical companies and medical device companies. The pharmaceutical and biopharmaceutical companies segment held a larger market share in 2022.

The Europe GMP testing service market, by country, is segmented into the Germany, the UK, Spain, Italy, France, and Rest of Europe. The Rest of Europe dominated the market share in 2022.

Eurofins Scientific; Almac Group; INTERTEK GROUP PLC; WuXi AppTec; Sartorius AG; North American Science Associates, Inc.; Nelson Laboratories, LLC.; and Thermo Fisher Scientific Inc. (PPD Inc.) are among the leading companies operating in the Europe GMP testing service market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe GMP testing service market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe GMP testing service market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe GMP testing service market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution